On Monday, Silence Therapeutics plc (NASDAQ: SLN) presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran in atherosclerotic cardiovascular disease (ASCVD) patients with high ...

Donald Trump has been somewhat cagey about his economic and tariff plans since voters elected him president, raising the stakes in a drawn-out contest to become his treasury secretary while focusing ...

Pixeldarts is set to transform social gatherings with a modern twist on traditional dart and throwing games. Created by Dartsnut —the innovative team behind the successful Chessnut Air and Evo ...